DarioHealth Corp.

Thank you. Thank you. . . . . . . . Good morning, ladies and gentlemen.

and welcome to the Dario Health second quarter 2026 results conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call has been recorded on Tuesday, August 11, 2026. I would now like to conference over to Zoe Harrison, VP Accounting and Corporate Development at Dario Health. Zoe, please go ahead.

Thank you, Operator, and good morning, everyone. Thank you for joining us today for a discussion of Daria Health's second quarter of 2026 financial results. Leading the call today will be Erez Raphael, Chief Executive Officer of Daria Health. He'll be joined by Hen Franker, our Chief Financial Officer, and our Chief Operating Officer, Lara Dodo, as Steven Nelson, the company's President and Chief Commercial Officer, is on medical leave. An audio recording and webcast replay for today's call will also be available online as detailed in the press release invite for this call. The benefit of those who may be listening to the replay or archived webcast, this call is being held on Tuesday, August 11, 2026. This morning, we issued a press release announcing our financial results for the second quarter of 2026. The copy of the release can be found on the investor relations page of Dario Health website. I'd like to remind you that on this call, management will make forward-looking statements within the meaning of the federal securities law. For example, the company is using forward-looking statements when it discusses expected revenue growth and contribution from signed accounts, its path to profitability and positive cash flow, the continued reduction in operating expenses and losses, its expansion of channel partnerships and distribution, expected revenue and scaling from partner-led opportunities, expected onboarding, implementation, and enrollment of large enterprise accounts. Expected conversion of contracted annual recurring revenue into recognized revenue Expected expansion into care delivery claims-based and outcomes-based models Expected benefits from care delivery participants Expected growth in recurring revenue and operating leverage Expected advantages and future impacts of Dario IQ and proprietary data assets Expected improvements in member engagement, retention, and outcomes The anticipated benefits of artificial intelligence across the company's commercial operations and internal operations The anticipated expansion of existing customer relationships into additional chronic conditions The expected timing and contribution of new product offerings The company's ability to increase revenue per customer through its multi-condition strategy The expected benefits of provider-backed clinical care And beliefs regarding competitive positioning and market opportunity Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond the company's control, including the risks described from time to time in its SEC filings. The company's results may differ materially from those projections. These statements involve material risks and uncertainties that could cause actual results or events to materially differ. Accordingly, you should not place undue reliance on these statements. I encourage you to review the company's filings with the SEC, including, without limitation, the company's annual report on Form 10-K, which identifies specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements. With that, I'll hand it over to Erez Raphael, Chief Executive Officer of Dario Health.